APA (7th ed.) Citation

AF, H., EY, C., SM, S., & KN, S. (2013). Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis. Obstetrics and gynecology, 122(3), 579. https://doi.org/10.1097/AOG.0b013e31829f8814

Chicago Style (17th ed.) Citation

AF, Hawk, Chang EY, Shields SM, and Simpson KN. "Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted Prophylaxis." Obstetrics and Gynecology 122, no. 3 (2013): 579. https://doi.org/10.1097/AOG.0b013e31829f8814.

MLA (9th ed.) Citation

AF, Hawk, et al. "Costs and Clinical Outcomes of Noninvasive Fetal RhD Typing for Targeted Prophylaxis." Obstetrics and Gynecology, vol. 122, no. 3, 2013, p. 579, https://doi.org/10.1097/AOG.0b013e31829f8814.